The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

We can add any view to the plot area using the PlotAreaBackgroundView support, which is useful for adding relevant data. In this example, we will compare the prevalence of type 1 diabetes in different ...